Every day, Celerion helps drug developers determine whether new drugs work in humans as they were designed.
Celerion provides the five key elements to successfully conduct Applied Translational Medicine.
Celerion comprises more than 1000 full-time scientific and medical personnel with the portfolio of skills to design, execute and interpret complex early clinical studies in healthy subjects and patients.
40 years of experience in early clinical research including over 6000 studies ensures quality data collected through efficient and effective study designs.
Facilities and Equipment
Celerion maintains clinic and laboratory facilities specially designed and equipped to meet the varying demands of early clinical research. Celerion is a leader in leveraging new technologies to provide better data, faster and at less cost.
Access to Patients
Through our clinics or relationships with specialty external laboratories and clinics, and a global network of experienced clinical sites, Celerion works to find the right patient or subject for “Clinical Proof-of-Concept,” “Clinical Proof-of-Mechanism,” or “Clinical Dose/Exposure-Response” studies.
Access to Biomarkers
Celerion leverages its own bioanalytical laboratories’ and clinic capabilities, as well as the services of expert vendors and academic collaborations, to provide the appropriate palate of tests to ascertain early signals of drug action and effect.